Skip to main content
OpenTrials

Clinical trial condition

Hematologic Malignancies

Explore clinical trials studying Hematologic Malignancies. Study availability and eligibility vary by location and protocol.

136 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Malignancies trial results

Active, not recruiting

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic Malignancies

NCT06645886

Conditions
Adult, Hematologic Diseases, Hematologic Malignancies, +4 more
Locations
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View all 29 locations
View Trial Details
Active, not recruiting

A Study of GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic Malignancy

NCT05104775

Conditions
Disease Attributes, Hematologic Diseases, Hematologic Malignancies, +11 more
Locations
  • Guangzhou First People's Hospital Guangzhou, Guangdong, China
  • Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
  • The Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China
  • Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Completed

A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma

NCT04696809

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations
  • Kameda Medical Center Chiba, Japan
  • Ogaki Municipal Hospital Gifu, Japan
  • National Hospital Organization Mito Medical Center Higashiibaraki-gun, Japan
  • Kobe City Medical Center General Hospital Kobe, Japan
View all 15 locations
View Trial Details

Related conditions